Reported Earnings • Jul 20
Full year 2026 earnings released: EPS: ₹12.32 (vs ₹11.19 in FY 2025) Full year 2026 results: EPS: ₹12.32 (up from ₹11.19 in FY 2025). Revenue: ₹5.91b (up 2.4% from FY 2025). Net income: ₹724.9m (up 10% from FY 2025). Profit margin: 12% (in line with FY 2025). Over the last 3 years on average, earnings per share has increased by 12% per year and the company’s share price has also increased by 12% per year. Ankündigung • Jul 17
Kothari Petrochemicals Limited, Annual General Meeting, Aug 14, 2026 Kothari Petrochemicals Limited, Annual General Meeting, Aug 14, 2026, at 11:00 Indian Standard Time. Reported Earnings • May 08
Full year 2026 earnings released: EPS: ₹12.32 (vs ₹11.19 in FY 2025) Full year 2026 results: EPS: ₹12.32 (up from ₹11.19 in FY 2025). Revenue: ₹6.00b (up 4.0% from FY 2025). Net income: ₹724.9m (up 10% from FY 2025). Profit margin: 12% (in line with FY 2025). Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 30% per year, which means it is tracking significantly ahead of earnings growth. Ankündigung • Apr 30
Kothari Petrochemicals Limited to Report Q4, 2026 Results on May 05, 2026 Kothari Petrochemicals Limited announced that they will report Q4, 2026 results on May 05, 2026 Valuation Update With 7 Day Price Move • Apr 06
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹110, the stock trades at a trailing P/E ratio of 9x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 88% over the past three years. Buy Or Sell Opportunity • Mar 27
Now 23% undervalued after recent price drop Over the last 90 days, the stock has fallen 24% to ₹99.79. The fair value is estimated to be ₹130, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.9% over the last 3 years. Earnings per share has grown by 16%. Reported Earnings • Feb 11
Third quarter 2026 earnings released: EPS: ₹3.18 (vs ₹2.18 in 3Q 2025) Third quarter 2026 results: EPS: ₹3.18 (up from ₹2.18 in 3Q 2025). Revenue: ₹1.35b (up 2.7% from 3Q 2025). Net income: ₹187.0m (up 46% from 3Q 2025). Profit margin: 14% (up from 9.8% in 3Q 2025). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 16% per year whereas the company’s share price has increased by 19% per year. Ankündigung • Jan 28
Kothari Petrochemicals Limited to Report Q3, 2026 Results on Feb 05, 2026 Kothari Petrochemicals Limited announced that they will report Q3, 2026 results on Feb 05, 2026 New Risk • Sep 23
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₹8.78b (US$99.0m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Market cap is less than US$100m (₹8.78b market cap, or US$99.0m). Reported Earnings • Aug 14
First quarter 2026 earnings released: EPS: ₹2.99 (vs ₹3.29 in 1Q 2025) First quarter 2026 results: EPS: ₹2.99 (down from ₹3.29 in 1Q 2025). Revenue: ₹1.61b (up 11% from 1Q 2025). Net income: ₹175.8m (down 9.2% from 1Q 2025). Profit margin: 11% (down from 13% in 1Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 26% per year whereas the company’s share price has increased by 28% per year. Reported Earnings • Jul 16
Full year 2025 earnings released: EPS: ₹11.19 (vs ₹10.84 in FY 2024) Full year 2025 results: EPS: ₹11.19 (up from ₹10.84 in FY 2024). Revenue: ₹5.77b (down 3.1% from FY 2024). Net income: ₹658.2m (up 3.2% from FY 2024). Profit margin: 11% (in line with FY 2024). Over the last 3 years on average, earnings per share has increased by 29% per year whereas the company’s share price has increased by 30% per year. Ankündigung • Jul 14
Kothari Petrochemicals Limited, Annual General Meeting, Aug 05, 2025 Kothari Petrochemicals Limited, Annual General Meeting, Aug 05, 2025, at 11:00 Indian Standard Time. New Risk • Mar 26
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.3% average weekly change). Valuation Update With 7 Day Price Move • Mar 21
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹164, the stock trades at a trailing P/E ratio of 15.1x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 77% over the past three years. Valuation Update With 7 Day Price Move • Feb 17
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to ₹141, the stock trades at a trailing P/E ratio of 13x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 70% over the past three years. New Risk • Feb 14
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₹8.51b (US$98.1m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₹8.51b market cap, or US$98.1m). Reported Earnings • Feb 11
Third quarter 2025 earnings released: EPS: ₹2.18 (vs ₹2.45 in 3Q 2024) Third quarter 2025 results: EPS: ₹2.18 (down from ₹2.45 in 3Q 2024). Revenue: ₹1.34b (up 6.9% from 3Q 2024). Net income: ₹128.5m (down 11% from 3Q 2024). Profit margin: 9.6% (down from 12% in 3Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has only increased by 22% per year, which means it is significantly lagging earnings growth. Reported Earnings • Nov 05
Second quarter 2025 earnings released: EPS: ₹2.77 (vs ₹3.15 in 2Q 2024) Second quarter 2025 results: EPS: ₹2.77 (down from ₹3.15 in 2Q 2024). Revenue: ₹1.84b (up 14% from 2Q 2024). Net income: ₹163.3m (down 12% from 2Q 2024). Profit margin: 8.9% (down from 12% in 2Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has increased by 59% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Oct 14
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹231, the stock trades at a trailing P/E ratio of 20.1x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 358% over the past three years. New Risk • Sep 14
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.9% average weekly change). Valuation Update With 7 Day Price Move • Aug 26
Investor sentiment improves as stock rises 24% After last week's 24% share price gain to ₹224, the stock trades at a trailing P/E ratio of 19.5x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 345% over the past three years. Buy Or Sell Opportunity • Aug 22
Now 23% overvalued after recent price rise Over the last 90 days, the stock has risen 46% to ₹195. The fair value is estimated to be ₹158, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 26% over the last 3 years. Earnings per share has grown by 33%. Reported Earnings • Aug 02
First quarter 2025 earnings released: EPS: ₹3.29 (vs ₹2.66 in 1Q 2024) First quarter 2025 results: EPS: ₹3.29 (up from ₹2.66 in 1Q 2024). Revenue: ₹1.49b (flat on 1Q 2024). Net income: ₹193.6m (up 24% from 1Q 2024). Profit margin: 13% (up from 11% in 1Q 2024). Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has increased by 43% per year, which means it is tracking significantly ahead of earnings growth. Ankündigung • Jul 27
Kothari Petrochemicals Limited Declares Final Dividend for the Financial Year 2023-2024 Kothari Petrochemicals Limited declared a final dividend of INR 1.00 (Rupee One Only) per Equity share of the face value of INR 10/- for the financial year 2023-2024. Valuation Update With 7 Day Price Move • Jul 25
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹177, the stock trades at a trailing P/E ratio of 16.4x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 322% over the past three years. Upcoming Dividend • Jul 11
Upcoming dividend of ₹1.00 per share Eligible shareholders must have bought the stock before 18 July 2024. Payment date: 24 August 2024. Payout ratio is a comfortable 16% and this is well supported by cash flows. Trailing yield: 1.2%. Within top quartile of Indian dividend payers (1.1%). Higher than average of industry peers (0.7%). Valuation Update With 7 Day Price Move • Jul 05
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹157, the stock trades at a trailing P/E ratio of 14.5x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 280% over the past three years. Ankündigung • Jul 04
Kothari Petrochemicals Limited, Annual General Meeting, Jul 25, 2024 Kothari Petrochemicals Limited, Annual General Meeting, Jul 25, 2024, at 11:00 Indian Standard Time. Reported Earnings • May 18
Full year 2024 earnings released: EPS: ₹10.84 (vs ₹6.66 in FY 2023) Full year 2024 results: EPS: ₹10.84 (up from ₹6.66 in FY 2023). Revenue: ₹6.11b (up 27% from FY 2023). Net income: ₹637.8m (up 63% from FY 2023). Profit margin: 10% (up from 8.1% in FY 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has increased by 48% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Apr 03
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹139, the stock trades at a trailing P/E ratio of 13.2x. Average trailing P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 446% over the past three years. Valuation Update With 7 Day Price Move • Feb 20
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹141, the stock trades at a trailing P/E ratio of 13.4x. Average trailing P/E is 31x in the Chemicals industry in India. Total returns to shareholders of 517% over the past three years. Declared Dividend • Feb 14
Dividend of ₹0.75 announced Shareholders will receive a dividend of ₹0.75. Ex-date: 19th February 2024 Payment date: 9th March 2024 Dividend yield will be 1.2%, which is higher than the industry average of 0.8%. Sustainability & Growth Dividend is well covered by both earnings (14% earnings payout ratio) and cash flows (18% cash payout ratio). The dividend has increased by an average of 7.2% per year over the past 10 years. However, payments have been volatile during that time. Earnings per share has grown by 51% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. New Risk • Feb 12
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₹7.64b (US$92.0m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₹7.64b market cap, or US$92.0m). Reported Earnings • Feb 10
Third quarter 2024 earnings released: EPS: ₹2.45 (vs ₹2.29 in 3Q 2023) Third quarter 2024 results: EPS: ₹2.45 (up from ₹2.29 in 3Q 2023). Revenue: ₹1.27b (down 10% from 3Q 2023). Net income: ₹144.1m (up 6.9% from 3Q 2023). Profit margin: 11% (up from 9.5% in 3Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has increased by 81% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Nov 11
Second quarter 2024 earnings released Second quarter 2024 results: Revenue: ₹1.63b (up 26% from 2Q 2023). Net income: ₹185.4m (up 95% from 2Q 2023). Profit margin: 11% (up from 7.3% in 2Q 2023). The increase in margin was driven by higher revenue. Valuation Update With 7 Day Price Move • Nov 10
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹152, the stock trades at a trailing P/E ratio of 17.3x. Average trailing P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 958% over the past three years. Valuation Update With 7 Day Price Move • Oct 11
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹147, the stock trades at a trailing P/E ratio of 16.6x. Average trailing P/E is 27x in the Chemicals industry in India. Total returns to shareholders of 888% over the past three years. Board Change • Sep 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 2 highly experienced directors. Additional Independent Director Brij Bansal was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Aug 10
First quarter 2024 earnings released: EPS: ₹2.66 (vs ₹0.51 in 1Q 2023) First quarter 2024 results: EPS: ₹2.66 (up from ₹0.51 in 1Q 2023). Revenue: ₹1.51b (up 105% from 1Q 2023). Net income: ₹156.6m (up 423% from 1Q 2023). Profit margin: 10% (up from 4.1% in 1Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has increased by 92% per year, which means it is tracking significantly ahead of earnings growth. New Risk • Jul 28
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (23% accrual ratio). Minor Risks Dividend is not well covered by cash flows (153% cash payout ratio). Share price has been volatile over the past 3 months (7.2% average weekly change). Market cap is less than US$100m (₹5.91b market cap, or US$71.7m). Ankündigung • Jul 18
Kothari Petrochemicals Limited, Annual General Meeting, Aug 09, 2023 Kothari Petrochemicals Limited, Annual General Meeting, Aug 09, 2023, at 14:00 Indian Standard Time. Agenda: To consider and adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2023, the Reports of the Auditors thereon and Report of the Board of Directors; to appoint a Director in the place of Mr. Arjun B Kothari, who retires by rotation and being eligible offers himself for re-appointment; to declare a final dividend of INR 0.75 paise (Seventy Five Paise only) per equity share of the face value of INR 10/- for the financial year 2022 - 2023; and to consider other matters. Valuation Update With 7 Day Price Move • Jul 12
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹92.35, the stock trades at a trailing P/E ratio of 13.9x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 489% over the past three years. Valuation Update With 7 Day Price Move • Jun 16
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to ₹79.10, the stock trades at a trailing P/E ratio of 11.9x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 442% over the past three years. Reported Earnings • May 30
Full year 2023 earnings released: EPS: ₹6.66 (vs ₹5.59 in FY 2022) Full year 2023 results: EPS: ₹6.66 (up from ₹5.59 in FY 2022). Revenue: ₹4.89b (up 28% from FY 2022). Net income: ₹391.8m (up 19% from FY 2022). Profit margin: 8.0% (down from 8.6% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Feb 08
Third quarter 2023 earnings released: EPS: ₹2.29 (vs ₹1.54 in 3Q 2022) Third quarter 2023 results: EPS: ₹2.29 (up from ₹1.54 in 3Q 2022). Revenue: ₹1.44b (up 36% from 3Q 2022). Net income: ₹134.8m (up 49% from 3Q 2022). Profit margin: 9.4% (up from 8.6% in 3Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has increased by 61% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Nov 03
Second quarter 2023 earnings released: EPS: ₹1.62 (vs ₹1.63 in 2Q 2022) Second quarter 2023 results: EPS: ₹1.62 (down from ₹1.63 in 2Q 2022). Revenue: ₹1.32b (up 44% from 2Q 2022). Net income: ₹95.3m (flat on 2Q 2022). Profit margin: 7.2% (down from 11% in 2Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has increased by 62% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Jul 10
Full year 2022 earnings released: EPS: ₹5.59 (vs ₹3.83 in FY 2021) Full year 2022 results: EPS: ₹5.59 (up from ₹3.83 in FY 2021). Revenue: ₹3.82b (up 68% from FY 2021). Net income: ₹328.9m (up 46% from FY 2021). Profit margin: 8.6% (down from 9.9% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has increased by 71% per year, which means it is tracking significantly ahead of earnings growth. Ankündigung • Jul 09
Kothari Petrochemicals Limited, Annual General Meeting, Aug 02, 2022 Kothari Petrochemicals Limited, Annual General Meeting, Aug 02, 2022, at 10:30 Indian Standard Time. Agenda: To consider and adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2022, the Reports of the Auditors thereon and Report of the Board of Directors; To appoint a Director in the place of Mrs.Nina B Kothari, (DIN: 00020119) who retires by rotation and being eligible offers herself for re-appointment; Re-appointment of Statutory Auditors for a second term of five years; and To discuss other matters. Valuation Update With 7 Day Price Move • Jun 20
Investor sentiment deteriorated over the past week After last week's 19% share price decline to ₹68.95, the stock trades at a trailing P/E ratio of 12.3x. Average trailing P/E is 16x in the Chemicals industry in India. Total returns to shareholders of 322% over the past three years. Reported Earnings • May 27
Full year 2022 earnings released: EPS: ₹5.59 (vs ₹3.83 in FY 2021) Full year 2022 results: EPS: ₹5.59 (up from ₹3.83 in FY 2021). Net income: ₹328.9m (up 46% from FY 2021). Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has increased by 66% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • May 11
Investor sentiment deteriorated over the past week After last week's 15% share price decline to ₹86.20, the stock trades at a trailing P/E ratio of 15.6x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 386% over the past three years. Valuation Update With 7 Day Price Move • Mar 14
Investor sentiment improved over the past week After last week's 20% share price gain to ₹99.20, the stock trades at a trailing P/E ratio of 17.9x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 414% over the past three years. Reported Earnings • Jan 28
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Third quarter 2022 results: EPS: ₹1.54 (up from ₹1.35 in 3Q 2021). Revenue: ₹1.07b (up 74% from 3Q 2021). Net income: ₹90.5m (up 14% from 3Q 2021). Profit margin: 8.5% (down from 13% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has increased by 71% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Dec 24
Investor sentiment improved over the past week After last week's 20% share price gain to ₹68.75, the stock trades at a trailing P/E ratio of 12.9x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 231% over the past three years. Reported Earnings • Nov 09
Second quarter 2022 earnings released: EPS ₹1.63 (vs ₹1.18 in 2Q 2021) The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2022 results: Revenue: ₹925.2m (up 31% from 2Q 2021). Net income: ₹95.7m (up 38% from 2Q 2021). Profit margin: 10% (in line with 2Q 2021). Over the last 3 years on average, earnings per share has increased by 34% per year whereas the company’s share price has increased by 33% per year. Valuation Update With 7 Day Price Move • Aug 31
Investor sentiment improved over the past week After last week's 16% share price gain to ₹56.85, the stock trades at a trailing P/E ratio of 11.6x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 148% over the past three years. Valuation Update With 7 Day Price Move • Aug 05
Investor sentiment improved over the past week After last week's 31% share price gain to ₹56.35, the stock trades at a trailing P/E ratio of 11.5x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 142% over the past three years. Reported Earnings • Jul 16
Full year 2021 earnings released: EPS ₹3.83 (vs ₹3.12 in FY 2020) The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: ₹2.29b (down 16% from FY 2020). Net income: ₹225.4m (up 23% from FY 2020). Profit margin: 9.8% (up from 6.7% in FY 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has only increased by 22% per year, which means it is significantly lagging earnings growth. Reported Earnings • May 25
Full year 2021 earnings released: EPS ₹3.83 (vs ₹3.12 in FY 2020) The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: ₹2.33b (down 15% from FY 2020). Net income: ₹225.4m (up 23% from FY 2020). Profit margin: 9.7% (up from 6.7% in FY 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • May 14
Investor sentiment improved over the past week After last week's 34% share price gain to ₹38.75, the stock trades at a trailing P/E ratio of 11.6x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 45% over the past three years. Valuation Update With 7 Day Price Move • Apr 27
Investor sentiment improved over the past week After last week's 21% share price gain to ₹29.75, the stock trades at a trailing P/E ratio of 8.9x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 6.0% over the past three years. Executive Departure • Apr 13
Company Secretary & Compliance Officer has left the company On the 10th of April, Deepa Bansal's tenure as Company Secretary & Compliance Officer ended after 1.7 years in the role. We don't have any record of a personal shareholding under Deepa's name. A total of 2 executives have left over the last 12 months. Valuation Update With 7 Day Price Move • Mar 01
Investor sentiment improved over the past week After last week's 28% share price gain to ₹29.60, the stock is trading at a trailing P/E ratio of 8.8x, up from the previous P/E ratio of 6.9x. This compares to an average P/E of 16x in the Chemicals industry in India. Total returns to shareholders over the past three years are 29%. Is New 90 Day High Low • Mar 01
New 90-day high: ₹29.60 The company is up 82% from its price of ₹16.25 on 01 December 2020. The Indian market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 11% over the same period. Ankündigung • Jan 28
Kothari Petrochemicals Limited Announces Resignation of Deepa Bansal, Company Secretary and Compliance Officer The Board of Directors of M/s. Kothari Petrochemicals Limited at its meeting held on January 27, 2021 has approved the resignation of Ms. Deepa Bansal, Company Secretary and Compliance Officer of the Company and accepted to relieve her from all responsibilities w.e.f. closing hours of April 10, 2021. Consequent to her resignation as Company Secretary and Compliance Officer, Ms. Deepa Bansal also ceases to be the Key Managerial Personnel of the Company effective closing hours of April 10, 2021. Reported Earnings • Jan 28
Third quarter 2021 earnings released: EPS ₹1.35 (vs ₹0.67 in 3Q 2020) The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: ₹625.4m (down 4.2% from 3Q 2020). Net income: ₹79.2m (up 101% from 3Q 2020). Profit margin: 13% (up from 6.0% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Jan 04
Investor sentiment improved over the past week After last week's 20% share price gain to ₹24.75, the stock is trading at a trailing P/E ratio of 9.3x, up from the previous P/E ratio of 7.7x. This compares to an average P/E of 18x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 16%. Is New 90 Day High Low • Dec 23
New 90-day high: ₹20.00 The company is up 29% from its price of ₹15.50 on 24 September 2020. The Indian market is up 19% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 18% over the same period. Is New 90 Day High Low • Dec 08
New 90-day high: ₹18.65 The company is up 24% from its price of ₹15.10 on 09 September 2020. The Indian market is up 18% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 18% over the same period. Reported Earnings • Nov 09
Second quarter 2021 earnings released: EPS ₹1.18 The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: ₹716.3m (up 7.1% from 2Q 2020). Net income: ₹69.5m (up 5.9% from 2Q 2020). Profit margin: 9.7% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings. Is New 90 Day High Low • Nov 04
New 90-day low: ₹14.55 The company is down 10.0% from its price of ₹16.15 on 06 August 2020. The Indian market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period. Is New 90 Day High Low • Oct 17
New 90-day low: ₹14.95 The company is down 5.0% from its price of ₹15.75 on 17 July 2020. The Indian market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 13% over the same period.